Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)

被引:665
作者
De Hert, M. [1 ]
Dekker, J. M. [2 ,3 ]
Wood, D. [4 ]
Kahl, K. G. [5 ]
Holt, R. I. G. [6 ]
Moeller, H. -J. [7 ]
机构
[1] Ctr Catholic Univ, Univ Psychiat, Leuven Campus Kortenberg,Leuvensesteenweg 517, B-3070 Kortenberg, Belgium
[2] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, NL-1081 BT Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Med Ctr, EMGO, Inst Hlth & Care Res, NL-1081 BT Amsterdam, Netherlands
[4] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst Cardiovasc Sci, London W6 8RP, England
[5] Hannover Med Sch, Dept Psychiat Social Psychiat & Psychotherapy, D-30625 Hannover, Germany
[6] Univ Southampton, Sch Med, Southampton SO16 6YD, Hants, England
[7] Univ Munich, Dept Psychiat, D-80336 Munich, Germany
关键词
Severe mental illness; Schizophrenia; Depression; Bipolar disorder; Physical health; Weight gain; INDUCED WEIGHT-GAIN; CATIE SCHIZOPHRENIA TRIAL; LIFE-STYLE INTERVENTION; ISCHEMIC-HEART-DISEASE; METABOLIC SYNDROME; ATYPICAL ANTIPSYCHOTICS; SCHIZOAFFECTIVE DISORDER; 2ND-GENERATION ANTIPSYCHOTICS; INSULIN SENSITIVITY; SEVERE DYSLIPIDEMIA;
D O I
10.1016/j.eurpsy.2009.01.005
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
People with severe mental illnesses, such as schizophrenia, depression or bipolar disorder, have worse physical health and reduced life expectancy compared to the general population. The excess cardiovascular mortality associated with schizophrenia and bipolar disorder is attributed in part to an increased risk of the modifiable coronary heart disease risk factors; obesity, smoking, diabetes, hypertension and dyslipidaemia. Antipsychotic medication and possibly other psychotropic medication like antidepressants can induce weight gain or worsen other metabolic cardiovascular risk factors. Patients may have limited access to general healthcare with less opportunity for cardiovascular risk screening and prevention than would be expected in a non-psychiatric population. The European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC) published this statement with the aim of improving the care of patients suffering from severe mental illness. The intention is to initiate cooperation and shared care between the different healthcare professionals and to increase the awareness of psychiatrists and primary care physicians caring for patients with severe mental illness to screen and treat cardiovascular risk factors and diabetes. (C) 2009 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:412 / 424
页数:13
相关论文
共 140 条
[1]   Obesity Among Those with Mental Disorders A National Institute of Mental Health Meeting Report [J].
Allison, David B. ;
Newcomer, John W. ;
Dunn, Andrea L. ;
Blumenthal, James A. ;
Fabricatore, Anthony N. ;
Daumit, Gail L. ;
Cope, Mark B. ;
Riley, William T. ;
Vreeland, Betty ;
Hibbeln, Joseph R. ;
Alpert, Jonathan E. .
AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2009, 36 (04) :341-350
[2]  
Allison DB, 1999, AM J PSYCHIAT, V156, P1686
[3]   Non-pharmacological management of anti psychotic-induced weight gain: systematic review and meta-analysis of randomised controlled trials [J].
Alvarez-Jimenez, Mario ;
Hetrick, Sarah E. ;
Gonzalez-Blanch, Cesar ;
Gleeson, John F. ;
McGorry, Patrick D. .
BRITISH JOURNAL OF PSYCHIATRY, 2008, 193 (02) :101-107
[4]  
Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI [10.2337/dc10-S011, 10.2337/dc11-S011, 10.2337/dc14-S081, 10.2337/dc12-s011, 10.2337/dc13-S011, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062, 10.2337/dc13-S067]
[5]   Standards of Medical Care in Diabetes-2009 [J].
不详 .
DIABETES CARE, 2009, 32 :S13-S61
[6]   Mortality of patients with mood disorders: follow-up over 34-38 years [J].
Angst, F ;
Stassen, HH ;
Clayton, PJ ;
Angst, J .
JOURNAL OF AFFECTIVE DISORDERS, 2002, 68 (2-3) :167-181
[7]  
[Anonymous], 2008, Can J Diabetes, V32, pS1, DOI DOI 10.1503/CMAJ.080554
[8]   A comparison of schizophrenia outpatients treated with antipsychotics with and without metabolic syndrome: Findings from the CLAMORS study [J].
Arango, Celso ;
Bobes, Julio ;
Aranda, Pedro ;
Carmena, Rafael ;
Garcia-Garcia, Margarida ;
Rejas, Javier .
SCHIZOPHRENIA RESEARCH, 2008, 104 (1-3) :1-12
[9]   Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia [J].
Barnett, A. H. ;
Mackin, P. ;
Chaudhury, I. ;
Farooqi, A. ;
Gadsby, R. ;
Heald, A. ;
Hill, J. ;
Millar, H. ;
Peveler, R. ;
Rees, A. ;
Singh, V. ;
Taylor, D. ;
Vora, J. ;
Jones, P. B. .
JOURNAL OF PSYCHOPHARMACOLOGY, 2007, 21 (04) :357-373
[10]  
Barrett E, 2004, OBES RES, V12, P362